GlaxoSmithKline Pharmaceuticals Limited ( GLAXO.BO) - Key Metrics
GLAXO.BO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ₹47.52 | ₹12.10 | ? | ? |
| 2025Q4 | ₹57.53 | ₹15.52 | ? | ? |
| 2024Q3 | ₹56.05 | ₹13.57 | ? | ? |
| 2024Q2 | ₹58.72 | ₹14.67 | ? | ? |
| 2024Q1 | ₹48.08 | ₹10.76 | ? | ? |
GLAXO.BO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 347.11% | 70.00 |
| 2025Q4 | ? | 45.06 |
| 2024Q3 | 88.43% | 41.49 |
| 2024Q2 | ? | 46.87 |
| 2024Q1 | 297.40% | 60.53 |
GLAXO.BO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | ? | 1.24% |
| 2025Q4 | ? | ? |
| 2024Q3 | ? | 0.53% |
| 2024Q2 | ? | ? |
| 2024Q1 | ? | 1.23% |
GLAXO.BO
Price: ₹2,332.85
Dividend Yield: 1.67%
Forward Dividend Yield: 2.44%
Payout Ratio: 84.68%
Dividend Per Share: 57.00 INR
Earnings Per Share: 56.30 INR
P/E Ratio: 44.63
Exchange: BSE
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 425.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 26
DGR3: 30.00%
DGR5: 30.00%
DGR10: 9.61%